Cellceutix, PolyMedix deal

Cellceutix acquired PolyMedix's assets, including the defunct biotech's pipeline of nine compounds as well as substantial equipment assets at PolyMedix's former headquarters and

Read the full 231 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE